Monday, June 22, 2026

Depo-Provera Meningioma Litigation Surges as Pfizer Reaches Tentative Global Settlement

Depo-Provera (MDL 3140) commanded the week's most significant developments, generating 117 new filings—led by McSweeney Langevin LLC (20) and Morgan & Morgan PA (17)—as the docket exploded to roughly 6,000 cases, adding more than 1,700 in a single month in the Northern District of Florida. In a pivotal development, Pfizer and plaintiff leadership reached a tentative global settlement in principle, referenced in Judge M. Casey Rodgers' latest pretrial order. The deal will not cover every claim: the three-day general-causation Daubert hearing still proceeds July 27, and the Toney v. Pfizer bellwether trial remains calendared for December 7. Elsewhere, the Suboxone dental decay litigation (MDL 3092) led raw weekly volume with 159 new complaints, Talcum Powder (MDL 2738) logged 106 new cases, Social Media Addiction (MDL 3047) added 76 filings, and AFFF (MDL 2873) drew 62 new actions. See the full filing feed and firm-level breakdowns here.

Cosmetics Giant L'Oréal Faces Class Actions Over Benzene in CeraVe Acne Products

On June 21, 2026, cosmetics giant L'Oréal, the parent company of CeraVe, faced a new wave of consumer class action lawsuits over allegations that its benzoyl peroxide-based acne products contain dangerous levels of benzene. The complaints, including In re CeraVe Acne Product Litigation, argue that the active acne-fighting ingredient benzoyl peroxide is unstable and degrades into the known human carcinogen under standard storage conditions. Plaintiffs assert that the manufacturer was aware of these degradation risks but failed to warn consumers or recall the affected treatments. The litigation seeks damages for consumer fraud, breach of express warranty, and unjust enrichment on behalf of affected buyers. This filing surge adds to the growing litigation landscape targeting benzene contamination in popular skincare and over-the-counter acne treatments.

Vermont Enacts Mandatory Heavy Metal Testing for Infant Food Manufacturers

On June 20, 2026, Vermont enacted a landmark food chemical safety law that imposes mandatory heavy metal testing on infant food products. The legislation, aimed at protecting child health, requires manufacturers to screen for toxic substances such as lead, arsenic, and mercury before products can be sold in the state. This regulatory development directly impacts the ongoing federal Baby Food Products Liability Litigation (MDL 3101), where manufacturers face hundreds of personal injury claims alleging that toxic heavy metals in their products caused neurological disorders in children. Under the new law, Vermont also implemented a strict ban on the herbicide paraquat, highlighting the state's aggressive stance on toxic chemical regulation. Attorneys in the coordinated federal litigation expect the new testing requirements to provide critical evidentiary support for plaintiffs seeking to establish industry-wide manufacturing standards.